KKR is facing a wave of investor redemption requests in its private credit funds, prompting withdrawal limits similar to ...

Spread the loveThe stock market is a constantly evolving landscape, with companies rising and falling based on a myriad of factors. As of April 11, 2026, significant news has emerged, particularly ...

If Biotech manages to break out to new highs at some point this year, it would clear a significant resistance hurdle and open ...

Investing in small biotech companies that make sufficient progress in regulatory approval and commercialization can ...

View Kazia Therapeutics Ltd Sponsored ADR KZIA stock quote prices, financial information, real-time forecasts, and company news from CNN.

Iovance Biotherapeutics argues that there is a meaningful opportunity here of more than 8,000 patients diagnosed annually in ...

Home prices across the New Jersey climbed nearly 6% in February compared to a year earlier, the sharpest gain of any state in ...

Backed by Novo Holdings and multiple other prominent investors, the biotech is developing what it’s positioning as superior ...

IBT's Ailsa Craig and Marek Poszepczynski give their key stock picks as companies move on from the science to commercial ...

Morgans healthcare analyst Iain Wilkie highlights seven ASX companies with upcoming catalysts in 2026 for investors to watch.

Avalyn Pharma is eyeing an IPO as the biotech seeks more funds to take its inhaled versions of approved drugs for lung ...

However, there is one key reason the stock could still deliver outstanding returns over the long run: Its pipeline could help ...